Preeclampsia

10%

10% of all pregnancies are
impacted by hypertension

14%

14% of all maternal deaths worldwide are due to hypertensive disorders

46%

46% of women with
gestational hypertension will
progress to preeclampsia

challenges

Preeclampsia and eclampsia increase risks of significant maternal and perinatal adverse outcomes. These may includeplacental abruption, preterm birth, and low birthweight.

Preeclampsia management is primarily focused on the therapy of maternal hypertension This can reduce the risk of severe hypertensive episodes and safely prolong gestation.

There is no accepted standard of the management of preeclampsia.

solution

SOLUTION

NICaS is designed to assist physicians to determine the exact cause of hypertension. NICaS is based on patients’ objective hemodynamic parameters which allow tphysicians a deeper understanding of the total dynamics concerning each patient’s hypertension. With NICaS, physicians can be more effective in prescribing the right medication for the right hypertension cause.

No more guessing what medication to administer —personalized treatment according to individual hemodynamic profile

NICaS eliminates hypertension as a risk factor that can cause complications during pregnancy